P63 in health and cancer

International Journal of Developmental Biology

Volumn 59, Issue 1-3, 2015, Pages 87-93

  Gonfloni, Stefania ^a   Caputo, Valerio ^a   Iannizzotto, Valentina ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cancer; DNA damage response; Genome stability; Metabolism; p63

Indexed keywords

GLUTATHIONE PEROXIDASE 2; MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN P53; PROTEIN P63; SIRTUIN 1; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; RNA SPLICING; TRANSACTIVATOR PROTEIN; TRP63 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; BINDING AFFINITY; CELL DEATH; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; ENERGY METABOLISM; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVITY; GENE EXPRESSION; GENE STRUCTURE; GENE TARGETING; GENOMIC INSTABILITY; GERM CELL; HEART DEVELOPMENT; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE; OOCYTE; ORGANOGENESIS; P63 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SKIN DEVELOPMENT; TUMOR INVASION; UPREGULATION; ALTERNATIVE RNA SPLICING; ANIMAL; CYTOLOGY; EMBRYOLOGY; EPIDERMIS; GENETICS; HEART; MALE; MOUSE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; RNA SPLICING; SPERMATOZOON; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; ANIMALS; DNA-BINDING PROTEINS; EPIDERMIS; GENES, TUMOR SUPPRESSOR; HEART; HUMANS; MALE; MICE; NEOPLASMS; NUCLEAR PROTEINS; OOCYTES; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RNA SPLICE SITES; SPERMATOZOA; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84940646963     PISSN: 02146282     EISSN: 16963547     Source Type: Journal    
DOI: 10.1387/ijdb.150045sg     Document Type: Article

References (62)

1. ADAMOVICH, Y, ADLER, J, MELTSER, V, REUVEN, N. and SHAUL, Y. (2014). AMPK couples p73 with p53 in cell fate decision. Cell Death Differ 21: 1451-1459.
2. ADORNO, M, CORDENONSI, M, MONTAGNER, M, DUPONT, S, WONG, C, HANN, B, SOLARI, A, BOBISSE, S, RONDINA, M.B, GUZZARDO, V. et al, (2009). A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137: 87-98.
3. AMELIO, I, GRESPI, F, ANNICCHIARICO-Petruzzelli, M. and MELINO, G. (2012). p63 the guardian of human reproduction. Cell Cycle 11: 4545-4551.
4. BAKKERS, J, HILD, M, KRAMER, C, FURUTANI-Seiki, M. and HAMMERSCHMIDT, M. (2002). Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. Dev Cell 2: 617-627.
5. BARBIERI, C.E, PEREZ, C.A, JOHNSON, K.N, ELY, K.A, BILLHEIMER, D. and PIETENPOL, J.A. (2005). IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res 65: 2314-2320.
6. BELLOMARIA, A, BARBATO, G, MELINO, G, PACI, M. and MELINO, S. (2012). Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction. Cell Cycle 11: 3638-3648.
7. BENARD, J, DOUC-Rasy, S. and AHOMADEGBE, J.C. (2003). TP53 family members and human cancers. Hum Mutat 21: 182-191.
8. BEYER, U, MOLL-Rocek, J, MOLL, U.M. and DOBBELSTEIN, M. (2011). Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci USA 108: 3624-3629.
9. BOTCHKAREV, V.A. and FLORES, E.R. (2014). p53/p63/p73 in the epidermis in health and disease. Cold Spring Harb Perspect Med 4.
10. CANDI, E, AGOSTINI, M, MELINO, G. and BERNASSOLA, F. (2014). How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mutat 35: 702-714.
11. CANDI, E, DINSDALE, D, RUFINI, A, SALOMONI, P, KNIGHT, R.A, MUELLER, M, KRAMMER, P.H. and MELINO, G. (2007). TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 6: 274-285.
12. CHAE, Y.S, KIM, H, KIM, D, LEE, H. and LEE, H.O. (2012). Cell density-dependent acetylation of DeltaNp63alpha is associated with p53-dependent cell cycle arrest. FEBS Lett 586: 1128-1134.
13. CHO, S.J, JUNG, Y.S. and CHEN, X. (2013). Poly (C)-binding protein 1 regulates p63 expression through mRNA stability. PLoS One 8: e71724.
14. COSTANZO, A, MERLO, P, PEDICONI, N, FULCO, M, SARTORELLI, V, COLE, P.A, FONTEMAGGI, G, FANCIULLI, M, SCHILTZ, L, BLANDINO, G. et al, (2002). DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell 9: 175-186.
15. COSTANZO, A, PEDICONI, N, NARCISI, A, GUERRIERI, F, BELLONI, L, FAUSTI, F, BOTTI, E. and LEVRERO, M. (2014). TP63 and TP73 in cancer, an unresolved “family” puzzle of complexity, redundancy and hierarchy. FEBS Lett 588: 2590-2599.
16. DAGUANNO, S, BARCAROLI, D, ROSSI, C, ZUCCHELLI, M, CIAVARDELLI, D, CORTESE, C, DE COLA, A, VOLPE, S, DAGOSTINO, D, TODARO, M. et al, (2014). p63 isoforms regulate metabolism of cancer stem cells. J Proteome Res 13: 2120-2136.
17. DE LAURENZI, V, COSTANZO, A, BARCAROLI, D, TERRINONI, A, FALCO, M, Annicchiarico-Petruzzelli, M, LEVRERO, M. and MELINO, G. (1998). Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 188: 1763-1768.
18. DEUTSCH, G.B, ZIELONKA, E.M, COUTANDIN, D, WEBER, T.A, SCHAFER, B, HANNEWALD, J, LUH, L.M, DURST, F.G, IBRAHIM, M, HOFFMANN, J. et al, (2011). DNA damage in oocytes induces a switch of the quality control factor TAp63alpha from dimer to tetramer. Cell 144: 566-576.
19. DOHN, M, ZHANG, S. and CHEN X. (2001). p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20: 3193-3205.
20. DOTSCH, V, BERNASSOLA, F, COUTANDIN, D, CANDI, E. and MELINO, G. (2010). p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2: a004887.
21. FLORES, E.R, SENGUPTA, S, MILLER, J.B, NEWMAN, J.J, BRONSON, R, CROWLEY, D, YANG, A, MCKEON, F. and JACKS, T. (2005). Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7: 363-373.
22. FLORES, E.R, TSAI, K.Y, CROWLEY, D, SENGUPTA, S, YANG, A, MCKEON, F. and JACKS, T. (2002). p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416: 560-564.
23. GANDELLINI, P, PROFUMO, V, CASAMICHELE, A, FENDERICO, N, BORRELLI, S, PETROVICH, G, SANTILLI, G, CALLARI, M, COLECCHIA, M, POZZI, S. et al, (2012). miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ 19: 1750-1760.
24. GONFLONI, S, IANNIZZOTTO, V, MAIANI, E, BELLUSCI, G, CICCONE, S. and DIEDERICH, M. (2014). P53 and Sirt1: Routes of metabolism and genome stability. Biochem Pharmacol 92: 149-56.
25. GREGORY, P.A, BERT, A.G, PATERSON, E.L, BARRY, S.C, TSYKIN, A, FARSHID, G, VADAS, M.A, Khew-Goodall, Y. and GOODALL, G.J. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
26. HUANG, Y, KESSELMAN, D, KIZUB, D, Guerrero-Preston, R. And RATOVITSKI, E.A. (2013). Phospho-DeltaNp63alpha/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure. Cell Cycle 12: 684-697.
27. JEONG, S.M, XIAO, C, FINLEY, L.W, LAHUSEN, T, SOUZA, A.L, PIERCE, K, LI, Y.H, WANG, X, LAURENT, G, GERMAN, N.J. et al, (2014). SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23: 450-463.
28. JUNG, Y.S, QIAN, Y, YAN, W. and CHEN, X. (2013). Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63. J Invest Dermatol 133: 1178-1187.
29. LI, C, CHANG, D.L, YANG, Z, QI, J, LIU, R, HE, H, LI, D. and XIAO, Z.X. (2013). Pin1 modulates p63alpha protein stability in regulation of cell survival, proliferation and tumor formation. Cell Death Dis 4: e943.
30. LI, C. and XIAO, Z.X. (2014). Regulation of p63 protein stability via ubiquitin-proteasome pathway. Biomed Res Int 2014: 175-721.
31. LI, Y, ZHOU, Z. and CHEN, C. (2008). WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ 15: 1941-1951.
32. MANTOVANI, F, PIAZZA, S, GOSTISSA, M, STRANO, S, ZACCHI, P, MANTOVANI, R, BLANDINO, G. and DEL SAL, G. (2004). Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 14: 625-636.
33. MARCEL, V, Dichtel-Danjoy, M.L, SAGNE, C, HAFSI, H, MA, D, ORTIZ-Cuaran, S, OLIVIER, M, HALL, J, MOLLEREAU, B, HAINAUT, P. et al, (2011). Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 18: 1815-1824.
34. MASSION, P.P, TAFLAN, P.M, JAMSHEDUR RAHMAN, S.M, YILDIZ, P, SHYR, Y, EDGERTON, M.E, WESTFALL, M.D, ROBERTS, J.R, PIETENPOL, J.A, CARBONE, D.P. et al, (2003). Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63: 7113-7121.
35. MELINO, G. (2011). p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 18: 1487-1499.
36. MULLER, P.A. and VOUSDEN, K.H. (2013). p53 mutations in cancer. Nat Cell Biol 15: 2-8.
37. Murray-Zmijewski, F, LANE, D.P. and BOURDON, J.C. (2006). p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13: 962-972.
38. NAPOLI, M. and FLORES, E.R. (2013). The family that eats together stays together: new p53 family transcriptional targets in autophagy. Genes Dev 27: 971-974.
39. OSADA, M, PARK, H.L, NAGAKAWA, Y, YAMASHITA, K, FOMENKOV, A, KIM, M.S, WU, G, NOMOTO, S, TRINK, B. and SIDRANSKY, D. (2005). Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 25: 6077-6089.
40. PARIS, M, ROULEAU, M, PUCEAT, M. and ABERDAM, D. (2012). Regulation of skin aging and heart development by TAp63. Cell Death Differ 19: 186-193.
41. Petre-Lazar, B, LIVERA, G, MORENO, S.G, TRAUTMANN, E, DUQUENNE, C, HANOUX, V, HABERT, R. and COFFIGNY, H. (2007). The role of p63 in germ cell apoptosis in the developing testis. J Cell Physiol 210: 87-98.
42. PICCOLO, S, ENZO, E. and MONTAGNER, M. (2013). p63, Sharp1, and HIFs: master regulators of metastasis in triple-negative breast cancer. Cancer Res 73: 4978-4981.
43. PIGNON, J.C, GRISANZIO, C, GENG, Y, SONG, J, SHIVDASANI, R.A. and SIGNORETTI, S. (2013). p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci USA 110: 8105-8110.
44. Reis-Filho, J.S, SIMPSON, P.T, MARTINS, A, PRETO, A, GARTNER, F. and SCHMITT, F.C. (2003). Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443: 122-132.
45. RIVETTIDI VAL CERVO, P, LENA, A.M, NICOLOSO, M, ROSSI, S, MANCINI, M, ZHOU, H, SAINTIGNY, G, DELLAMBRA, E, ODORISIO, T, MAHE, C. et al, (2012). p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci USA 109: 1133-1138.
46. ROEMER, K. (2012). Notch and the p53 clan of transcription factors. Adv Exp Med Biol 727: 223-240.
47. ROSSI, M, AQEILAN, R.I, NEALE, M, CANDI, E, SALOMONI, P, KNIGHT, R.A, CROCE, C.M. and MELINO, G. (2006). The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci USA 103: 12753-12758.
48. RUFINI, A, TUCCI, P, CELARDO, I. and MELINO, G. (2013). Senescence and aging: the critical roles of p53. Oncogene 32: 5129-5143.
49. SAMMONS, M.A, ZHU, J, DRAKE, A.M. and BERGER, S.L. (2014). TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity. Genome Res 25: 179-88.
50. SASAKI, Y, NAISHIRO, Y, OSHIMA, Y, IMAI, K, NAKAMURA, Y. and TOKINO, T. (2005). Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes. Oncogene 24: 5131-5136.
51. SENOO, M, PINTO, F, CRUM, C.P. and MCKEON, F. (2007). p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129: 523-536.
52. SHAW, P.E. (2002). Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Rep 3: 521-526.
53. STRANO, S, MONTI, O, PEDICONI, N, BACCARINI, A, FONTEMAGGI, G, LAPI, E, MANTOVANI, F, DAMALAS, A, CITRO, G, SACCHI, A. et al, (2005). The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 18: 447-459.
54. SU, X, CHAKRAVARTI, D, CHO, M.S, LIU, L, GI, Y.J, LIN, Y.L, LEUNG, M.L, El-Naggar, A, CREIGHTON, C.J, SURAOKAR, M.B. et al, (2010). TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986-990.
55. SU, X, GI, Y.J, CHAKRAVARTI, D, CHAN, I.L, ZHANG, A, XIA, X, TSAI, K.Y. and FLORES, E.R. (2012). TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab 16: 511-525.
56. SUH, E.K, YANG, A, KETTENBACH, A, BAMBERGER, C, MICHAELIS, A.H, ZHU, Z, ELVIN, J.A, BRONSON, R.T, CRUM, C.P. and MCKEON, F. (2006). p63 protects the female germ line during meiotic arrest. Nature 444: 624-628.
57. TRAN, M.N, CHOI, W, WSZOLEK, M.F, NAVAI, N, LEE, I.L, NITTI, G, WEN, S, FLORES, E.R, Siefker-Radtke, A, CZERNIAK, B. et al, (2013). The p63 protein isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem 288: 3275-3288.
58. TUCCI, P, AGOSTINI, M, GRESPI, F, MARKERT, E.K, TERRINONI, A, VOUSDEN, K.H, MULLER, P.A, DOTSCH, V, KEHRLOESSER, S, SAYAN, B.S. et al, (2012). Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 109: 15312-15317.
59. WESTFALL, M.D, MAYS, D.J, SNIEZEK, J.C. and PIETENPOL, J.A. (2003). The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264-2276.
60. WU, G, NOMOTO, S, HOQUE, M.O, DRACHEVA, T, OSADA, M, LEE, C.C, DONG, S.M, GUO, Z, BENOIT, N, COHEN, Y. et al, (2003). DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63: 2351-2357.
61. YANG, A, KAGHAD, M, WANG, Y, GILLETT, E, FLEMING, M.D, DOTSCH, V, ANDREWS, N.C, CAPUT, D. and MCKEON, F. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316.
62. YING, H, CHANG, D.L, ZHENG, H, MCKEON, F. and XIAO, Z.X. (2005). DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol Cell Biol 25: 6154-6164.